×

BRIEF-Biogen says found additional treatment evidence for multiple sclerosis drug

Oct 12 (Reuters) - Biogen Idec Inc :

* New data from phase 3 studies provide additional evidence supporting

treatment effect for oral bg-12 (dimethyl fumarate) in multiple sclerosis

* Says interim results from endorse extension study further support safety

profile from pivotal studies

* Dimethyl fumarate showed statistically significant,clinically relevant

effects in reducing multiple sclerosis relapses

* Source text * Further company coverage ((Bangalore Newsroom; +1 646 223 8780))